Portfolio company
Nyra Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
Cardiac Dimensions
This company develops minimally invasive heart implants to treat functional mitral regurgitation in patients with heart failure.
HighLife Medical
HighLife Medical develops transcatheter mitral valve replacement systems for patients suffering from moderate to severe mitral regurgitation.